full reportFull record · 859793007327 · back to the summary
Free to read, download and share — no signup, no paywall, no ads.
What this is. We compare what a listing claims against what public records show — label arithmetic, barcode registries, NIH’s label catalog, FDA enforcement data, certification registries, and published research. Every statement below traces to one of those.
What the states mean. Confirmed = an outside source agrees. Contradicted = an outside source disagrees. Caution = something needs explaining. No data = we looked and found nothing — a gap, not a strike.
What it is not. A clean record is not an endorsement and never proof a product works. A thin record is not an accusation. We publish evidence and gaps; the conclusion is yours. Nothing here is medical advice.
Something wrong? Every figure is meant to be checkable — sources are named and linked. Send a correction and we’ll fix the record.
We did the comparison: the listing claims 250 mg of nicotinamide mononucleotide, and the listing-image panel shows 250 mg nicotinamide mononucleotide 2 capsules. Those amounts agree. This is internal consistency, not independent lab testing.
| Panel row | Amount | %DV | What to notice |
|---|---|---|---|
| Nicotinamide Mononucleotide | 250 mg | — |
FDA rules (21 CFR 101.36) require the amount of each dietary ingredient per serving unless hidden in a listed “proprietary blend” (legal, but a transparency yellow flag). A label stating no amount at all is non-compliant — a checkable red flag. This panel states amounts; any remaining comparison concerns the front-label framing.
vision:google/gemini-2.5-flash Amounts are shown as listed panel data, not independently lab-tested contents.
Every check we ran
Confirmed evidence
These checks found support in the public record. They confirm specific facts, not the product as a whole.
label claims 250 mg/serving — within the range commonly used in research (human trials to date mostly use 250–1,000 mg/day). Sources: PubMed search: nicotinamide mononucleotide human trial, ClinicalTrials.gov — NMN.
UPCitemdb resolves 859793007327 to "Nicotinamide Mononucleotide (Nmn) - 60 capsules, 250 mg servings" (Double Wood Supplements) — consistent with this listing.
The panel gives a per-ingredient amount rather than hiding quantities inside a proprietary blend, so each one can be compared to published research.
USPTO lists Double Wood LLC (LIMITED LIABILITY COMPANY) in PENNSYLVANIA, USA for the exact brand wordmark. This identifies the USPTO mark owner or applicant; it does not by itself prove who manufactures or sells this product.
Documented concerns
These are documented contradictions or claims that need more evidence. They are separate from missing data.
No contradictions or product-specific cautions were found at this check depth.
Unresolved public record
We looked for these signals but could not settle them from public sources. A gap is not a strike.
The listing claims 250 mg; the photo-read Supplement Facts panel shows Nicotinamide Mononucleotide at 250 mg per serving — the listing text and its photo-read panel agree; this is internal consistency, not independent testing.
Published sources describe how NMN have been studied. This is ingredient context only; the record does not establish that this product delivers the studied dose or outcome. Sources: PubMed search: nicotinamide mononucleotide human trial, ClinicalTrials.gov — NMN.
We have not found a public label filing for this exact product. That is a gap in our records, not evidence that no filing exists.
Exact-listing history records written-review counts from 748 on 2025-10-28 to 749 on 2025-11-15 (net +1). Count movements can reflect sales, listing variants, collection resets, or moderation; this history does not establish whether reviews are authentic.
The package says manufactured by: Brand Nutraceuticals Inc.. USPTO names Double Wood LLC as the exact wordmark owner. That can be a normal distributor, manufacturer, or licensing relationship; the saved records do not establish the relationship.
What to ask and check
Ask the brand or seller
Answered by the panel: 0.25 g of the 0.25 g headline is nicotinamide mononucleotide. Which independent lab can confirm that amount in this product?
The panel resolves the front-label arithmetic. The remaining question is lot-specific contents and stability; published category testing gives context, not a test of this product.
Is this label filed with NIH’s Dietary Supplement Label Database (DSLD)?
Filing is voluntary, so absence proves nothing — but a filed label puts the full ingredient table on public record where anyone can read it.
Where are the ingredients sourced, and where is the product manufactured?
“Made in USA” can describe only the final bottling step. Ask which country the actives came from and whether the facility is audited.
Most brands and sellers publish a contact route. A clear answer adds evidence to the record; no answer leaves the question open.
Check for yourself — no one’s permission needed
Compare the panel on the bottle in your hand to the one shown in this record.
Ours was read from listing photos and can contain reading errors. The physical label is the source of truth — if they disagree, tell us and we’ll correct the record.
Scan the barcode on the package and confirm it reads 859793007327.
A mismatch between the barcode on the box and the one on the listing is worth pausing over — it can indicate a different variant, a repack, or a counterfeit.
Check the lot number and expiry on the bottle against any COA you’re given.
A certificate that doesn’t name your lot doesn’t describe what you’re holding.
These are the open questions on this specific record — not a warning about the product, and not a suggestion to buy or avoid it. Getting them answered is how you decide for yourself.
What the listing promises — claim by claim
| Claim | Status | What we found |
|---|---|---|
| Manufacturing claim “…MANUFACTURED TO THE HIGHEST STANDARDS: Made in the USA in a GMP-compliant facility, Double Wood's NMN is non-GMO and gluten-free…” | Partly supported We looked for: the facility registration or certificate behind the claim | “GMP-certified” describes factory processes, not what is in the bottle. The claim does not name a certifier or public register that a shopper can check. |
| Origin claim “…MANUFACTURED TO THE HIGHEST STANDARDS: Made in the USA in a GMP-compliant facility, Double Wood's NMN is non-GMO and gluten-free…” | Claimed, not verifiable We looked for: customs records or label filings showing where ingredients were sourced and where it was made | “Made in USA” can describe only final bottling. Ingredient-sourcing records were not located for this product. |
| Benefit claim “…SUPPORTS NAD+ FOR CELLULAR ENERGY AND HEALTHY AGING: NMN is a direct precursor to NAD+, a critical molecule that drives cellular energy metabolism and vitality — and Dou” | Partly supported We looked for: whether the ingredient doses on the label match the doses used in published research | Ingredient evidence exists; on dose: label claims 250 mg/serving — within the range commonly used in research (human trials to date mostly use 250–1,000 mg/day). |
“No evidence located” does not mean a claim is false — it means the seller has not put evidence proportionate to the claim on the public record, and we could not find any. Absence of proof is not proof of absence.
This label vs. the doses studied
| Ingredient | Where this label sits | Reading |
|---|---|---|
| Nicotinamide Mononucleotide | shaded = doses used in studies (250 mg–1 g) · bar = this label | 250 mg — within the studied range |
Matching a studied dose does not mean the product works, and missing it does not mean it fails — it shows whether the label and the research are talking about the same amounts. Not a recommendation to take any amount.
Verifiability profile — 3 of 6 public signals
What this listing gives the public to check. Publishing these signals doesn't prove quality — but withholding them means claims can only be taken on faith.
Identity
| UPC (barcode) — also our record ID | 859793007327 — via source listing UPC |
| Brand | Double Wood Supplements |
| Source listing identifier | B07SVG5N45 |
| Retailer listing title | NMN Supplement - 99% Purity Tested - 125mg per Capsule of Nicotinamide… show full titleNMN Supplement - 99% Purity Tested - 125mg per Capsule of Nicotinamide Mononucleotide, 60 Capsules, by Double Wood Supplements |
| USPTO brand owner | Double Wood LLC · LIMITED LIABILITY COMPANY · PENNSYLVANIA, USA |
| Owner filed address | 22 Lindsey Ave, Danville, PENNSYLVANIA 17821, UNITED STATES |
From the label (photo-read)
| Serving size | 2 Capsules |
| Pack statement | 60 Capsules |
| Badges printed on pack | GLUTEN FREE, PROUDLY MANUFACTURED IN THE USA, MADE WITH NON-GMO INGREDIENTS, GLUTEN |
Supplement Facts panel (photo-read):
| Ingredient | Amount per serving | Reading confidence |
|---|---|---|
| Nicotinamide Mononucleotide | 250 mg | High clearly legible in the photo |
Claims printed on the packaging:
“NICOTINAMIDE MONONUCLEOTIDE” · “250 mg per serving” · “Dietary Supplement” · “NMN helps boost NAD+ levels, while Resveratrol activates sirtuins that rely on NAD+ to function.” · “Together, they work synergistically to support energy, metabolic health, and overall wellness as you age.” · “NMN Supplement” · “New” · “NMN is a direct precursor to NAD+”
Read by a vision model from 5 listing photos — verbatim extraction; OCR errors possible. Spot a mistake? It will be corrected on review.
Where it sells
| Seller | Price |
|---|---|
| Retailer listing ↗ | $32.95 checked Sep 03, 2026 — varies by variant/session; price history pending |
Brand store doublewoodsupplements.com: 197 supplement products (+6 merch items) — for comparison, single-focus brands typically carry 5–30 products; very broad catalogs are common among companies that rebrand ready-made formulas — a pattern note, not a verdict.
Reference links for identification only — LookCloser has no affiliate relationships and earns nothing from any link on this page.
Ingredient science — NIH references
Niacin — NIH ODS · MedlinePlus · PubMed (2,689) · UL 35 mg (supplemental/added niacin, adults)
Reference data from the NIH Office of Dietary Supplements, IOM Dietary Reference Intakes, and PubMed. A Tolerable Upper Intake Level is a documented reference figure, not a safety verdict — both the listed amount and the reference are shown for your own judgment. LookCloser gives no medical advice.
Related research & consistency
NMN (nicotinamide mononucleotide) — PubMed search: nicotinamide mononucleotide human trial · ClinicalTrials.gov — NMN · ClinicalTrials.gov — 39 registered studies
✓ Dosage: label claims 250 mg/serving — within the range commonly used in research (human trials to date mostly use 250–1,000 mg/day).
ℹ Use pattern in research: trials report raised NAD+ blood markers; whether that produces anti-aging or energy outcomes people care about remains unsettled in humans.
These notes state where label numbers and marketing framing sit relative to published research — documentation for your own judgment, not medical advice. LookCloser does not advise for or against taking any supplement.
Record 859793007327 · built September 03, 2026 · lookcloser.ai · corrections@lookcloser.ai